logo

For the Inventor, By the Inventor

Lund, Sweden

Jan W Trofast

This inventor holds 23 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Inhalation Devices. Top assignees: Astra Aktiebolag, Astrazeneca Ab, Aktiebolaget Draco. Active years: 1987-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan W Trofast. Retrieved from https://idiyas.com/inventor/jan-w-trofast

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 73.9

 

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 580(Granted Patents)


Company Filing History:

goldMedal10 out of 271 
 
Astra Aktiebolag
 patents
silverMedal7 out of 1,531 
 
Astrazeneca Ab
 patents
bronzeMedal4 out of 40 
 
Aktiebolaget Draco
 patents
4. 2 out of 53 
 
Aktiebolaget Astra
 patents

Years Active: 1987-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Budesonide
Formoterol
Inhaler
Inhalation Device
Respirable Particles
Bronchodilator
Steroidal Anti-Inflammatory
Pharmaceutical Formulation
Liposomes
H+, K+-ATPase Inhibitor
Widal's Syndrome
Nasal Polyps
23 patents (USPTO):Explore Patents
1. 8461211 - Use for budesonide and formoterol (2013-06-11),
2. 7897646 - Use for budesonide and formoterol (2011-03-01),
3. 7841340 - Inhaler with powder dislodging member (2010-11-30),
4. 7779836 - Inhalation device (2010-08-24),
5. 6655380 - Inhalation device (2003-12-02),
6. 6599927 - Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome (2003-07-29),
7. 6380222 - Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps (2002-04-30),
8. 6287540 - Formulation for inhalation (2001-09-11),
9. 6221398 - Process for the preparation of respirable particles (2001-04-24),
10. 6199607 - Formulation for inhalation (2001-03-13),
11. 6030604 - Formulation for inhalation (2000-02-29),
12. 6027714 - Formulation for inhalation (2000-02-22),
13. 5983956 - Formulation for inhalation (1999-11-16),
14. 5980949 - Formulation for inhalation (1999-11-09),
15. 5972919 - Combination of a bronchodilator and a steroidal anti-inflammatory drug (1999-10-26),

Title: Innovator Spotlight: Jan W. Trofast

Introduction: Jan W. Trofast, based in Lund, Sweden, is a prolific inventor known for his contributions to medical advancements. With a remarkable portfolio comprising 23 patents, he has significantly impacted the treatment of chronic respiratory conditions.

Latest Patents: Among his most notable inventions is the use of budesonide and formoterol in treating chronic obstructive pulmonary disease (COPD). His innovative work has demonstrated the effectiveness of combining these two compounds, paving the way for improved therapeutic options for patients suffering from this debilitating condition.

Career Highlights: Jan's career includes significant stints at leading pharmaceutical companies such as Astra Aktiebolag and AstraZeneca AB. His expertise and dedication to research have contributed to the development of essential medications that have improved the quality of life for many individuals.

Collaborations: Throughout his career, Jan has collaborated with esteemed colleagues including Edib Jakupovic and Bengt I. Axelsson. Their combined efforts in research and development have fostered innovative solutions in the pharmaceutical arena.

Conclusion: Jan W. Trofast stands out as a key figure in the field of pharmaceutical innovations. His enduring commitment to research and the successful application of his patents underscore his role as a vital contributor to advancements in medical treatments, particularly for chronic obstructive pulmonary disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…